CVS Group plc (LON:CVSG - Get Free Report)'s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,247.82 and traded as low as GBX 1,218.83. CVS Group shares last traded at GBX 1,236, with a volume of 20,419,254 shares traded.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Tuesday, May 26th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, CVS Group has an average rating of "Moderate Buy" and an average price target of GBX 1,724.
Get Our Latest Analysis on CVSG
CVS Group Stock Performance
The company's fifty day moving average price is GBX 1,195.82 and its two-hundred day moving average price is GBX 1,247.82. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The firm has a market capitalization of £856.00 million, a PE ratio of 17.95, a price-to-earnings-growth ratio of 1.77 and a beta of 1.06.
CVS Group announced that its Board of Directors has initiated a stock repurchase plan on Tuesday, May 26th that authorizes the company to repurchase 0 shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's management believes its shares are undervalued.
Insider Activity at CVS Group
In other CVS Group news, insider Scott Morrison bought 987 shares of the company's stock in a transaction dated Wednesday, May 27th. The shares were acquired at an average cost of GBX 1,270 per share, with a total value of £12,534.90. Insiders own 1.43% of the company's stock.
CVS Group Company Profile
(
Get Free Report)
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.